Itai Yanai

Itai Yanai is a Professor in the Department of Biochemistry and Molecular Pharmacology at NYU Grossman School of Medicine and serves as Scientific Director of the Applied Bioinformatics Laboratories. His primary research focuses on the intersection of computational biology, genomics, and developmental genetics with significant contributions to understanding cancer biology and microbial systems.

Dr. Yanai's research spans multiple domains including cancer biology, computational approaches to genomics, and developmental genetics. His work particularly emphasizes single-cell transcriptomics, gene expression atlas construction, and the application of systems biology approaches to understand complex biological phenomena. A significant portion of his research investigates developmental constraints and their implications for cancer evolution and tumor heterogeneity.

Analysis of Dr. Yanai's recent publications reveals a strong focus on applying cutting-edge computational methods to biological problems, with particular emphasis on single-cell RNA sequencing applications. His work bridges cancer research, developmental biology, and microbiome studies, demonstrating how evolutionary principles inform our understanding of disease mechanisms. The publications show increasing integration of computational approaches with experimental validation across diverse biological systems.

Dr. Yanai leads an active research laboratory that maintains a strong publication record, with recent work appearing in high-impact journals including Nature, Cell, and Nature Genetics. His laboratory appears to focus on interdisciplinary approaches that combine wet-lab experimentation with computational analysis, particularly in the areas of single-cell technologies and evolutionary developmental biology.

The Yanai Lab maintains an active presence through its website (yanailab.org) and additional outreach initiatives including the Night Science Podcast. The laboratory appears to focus on both fundamental biological questions related to developmental constraints and translational applications in cancer research, with particular emphasis on understanding cellular adaptation mechanisms in disease contexts.